There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, ...
The GLP-1 maker’s latest AI investment targets drug discovery and the future of consumer medicine.
Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. From your friendly ...
Needle exchanges in Western Australia are reporting dramatic increases in people accessing their services for peptide use.
Aprepitant injections are in a class of medications called antiemetics. They work by blocking the action of neurokinin, a natural substance in the brain that causes nausea and vomiting. Aprepitant ...
Researchers at the Terasaki Institute for Biomedical Innovation have developed an injectable hydrogel, a water-based gel ...
Tougher regulation on peptide supplies is needed as illegal use skyrockets among young Australians, University of Queensland researchers say. Dr. Timothy Piatkowski, of UQ's School of Public Health, ...
Up to one in three participants on semaglutide 7.2 mg achieved at least 25% weight loss over 72 weeksMean weight loss with semaglutide 7.2 mg reached 21%, reflecting overall treatment efficacyUp to 84 ...
(NYSE: BHC)(TSX: BHC), announces the listing of PrOKEDI® (extended-release injectable suspension of risperidone) 75 mg and 100 mg strengths to the drug formulary of the Régie de l'assurance maladie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results